The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome
- PMID: 30996192
- PMCID: PMC6746644
- DOI: 10.2169/internalmedicine.2661-19
The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome
Keywords: Stenotrophomonas maltophilia; fluoroquinolone; immunosuppressive; sulfamethoxazole-trimethoprim.
Conflict of interest statement
Comment in
-
The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome".Intern Med. 2019 Aug 15;58(16):2421. doi: 10.2169/internalmedicine.2793-19. Epub 2019 Apr 17. Intern Med. 2019. PMID: 30996197 Free PMC article. No abstract available.
Comment on
-
Fatal Neutropenic Enterocolitis Caused by Stenotrophomonas maltophilia: A Rare and Underrecognized Entity.Intern Med. 2018 Dec 15;57(24):3667-3671. doi: 10.2169/internalmedicine.1227-18. Epub 2018 Aug 10. Intern Med. 2018. PMID: 30101922 Free PMC article.
References
-
- Cooley L, Dendle C, Wolf J, et al. . Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 44: 1350-1363, 2014. - PubMed
-
- Green H, Paul M, Vidal L, et al. . Prophylaxis of Pneumocystis pneumonia in immunocompromised Non-HIV-infected patients: systematic review and meta-analysis of randomized cotrolled trials. Mayo Clin Proc 82: 1052-1059, 2007. - PubMed
-
- Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9: 312-323, 2009. - PubMed